𝔖 Bobbio Scriptorium
✦   LIBER   ✦

108 THE FIRST REPORT FROM THE IRISH PROSTATE CANCER RESEARCH CONSORTIUM: A PROFILE OF PSAAND PATHOLOGICAL PARAMETERS IN IRISH MEN WITH PROSTATE CANCER

✍ Scribed by A. Perry; C. Powell; T. Lynch; J. Fitzpatrick; K. O'Malley; E. Gaffney; B. Dunne; C. O'Keane; D. Hollywood; M. Lawler; W. Watson

Book ID
119617440
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
317 KB
Volume
6
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can multiparametric magnetic resonance i
Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St PeterΧ³s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.
✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko πŸ“‚ Article πŸ“… 2014 πŸ› Elsevier Science 🌐 English βš– 415 KB